Skip to the page

Data / Drug companies / Cyproheptadine hydrochloride

Cyproheptadine hydrochloride: 24 companies and 38 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Cyproheptadine hydrochloride is listed in the FDA National Drug Code Directory by 24 companies, with 38 products in commercial distribution. 38 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; solution; syrup, and the newest product started marketing on October 15, 2026.

The request: Get every company that lists cyproheptadine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
24
Products
38
Generic (ANDA) products
38 (100.0%)
Application numbers
14
Routes
Oral
Brand names
Cyproheptadine
openFDA record search
api.fda.gov

Companies that list cyproheptadine hydrochloride

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Bryant Ranch Prepack5tabletGeneric drugs (ANDA)February 24, 2021
Quagen Pharmaceuticals LLC4solution; tabletGeneric drugs (ANDA)October 15, 2026
A-S Medication Solutions2tabletGeneric drugs (ANDA)July 20, 2017
Atlantic Biologicals Corp.2solution; syrupGeneric drugs (ANDA)December 22, 2023
Bryant Ranch Prepack2tablet; solutionGeneric drugs (ANDA)February 24, 2021
Chartwell RX, LLC2tablet; syrupGeneric drugs (ANDA)July 13, 2017
QPharma, Inc.2tabletGeneric drugs (ANDA)February 24, 2021
Remedyrepack Inc.2tabletGeneric drugs (ANDA)May 27, 2026
TruPharma, LLC2tabletGeneric drugs (ANDA)June 1, 2026
Amneal Pharmaceuticals of New York LLC1tabletGeneric drugs (ANDA)July 29, 2015
AvPAK1tabletGeneric drugs (ANDA)October 30, 2025
Cranbury Pharmaceuticals, LLC1syrupGeneric drugs (ANDA)December 21, 2021
Golden State Medical Supply, Inc.1tabletGeneric drugs (ANDA)September 23, 2015
Ingenus Pharmaceuticals, LLC1tabletGeneric drugs (ANDA)September 23, 2015
Method Pharmaceuticals, LLC1solutionGeneric drugs (ANDA)June 15, 2024
PD-Rx Pharmaceuticals, Inc.1tabletGeneric drugs (ANDA)March 1, 2020
Pangea Pharmaceuticals, LLC1tabletGeneric drugs (ANDA)October 12, 2026
Patrin Pharma, Inc.1solutionGeneric drugs (ANDA)February 15, 2022
Rising Pharma Holdings, Inc.1tabletGeneric drugs (ANDA)February 9, 2022
Rising Pharma Holdings, Inc.1syrupGeneric drugs (ANDA)July 10, 2006
Strides Pharma Science Limited1tabletGeneric drugs (ANDA)April 11, 2018
Unichem Pharmaceuticals (USA), Inc.1tabletGeneric drugs (ANDA)March 1, 2020
Zydus Lifesciences Limited1tabletGeneric drugs (ANDA)July 20, 2017
Zydus Pharmaceuticals USA Inc.1tabletGeneric drugs (ANDA)July 20, 2017

Dosage forms

Dosage formProductsShare
Tablet2873.7%
Solution615.8%
Syrup410.5%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)38100%

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.